BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gentilucci UV, Gallo P, Perrone G, Vescovo RD, Galati G, Spataro S, Mazzarelli C, Pellicelli A, Afeltra A, Picardi A. Non-cirrhotic portal hypertension with large regenerative nodules: A diagnostic challenge. World J Gastroenterol 2011; 17(20): 2580-2584 [PMID: 21633664 DOI: 10.3748/wjg.v17.i20.2580]
URL: https://www.wjgnet.com/1007-9327/full/v17/i20/2580.htm
Number Citing Articles
1
Kazushi Numata, Hiroyuki Fukuda, Hiromi Nihonmatsu, Masaaki Kondo, Akito Nozaki, Makoto Chuma, Manabu Morimoto, Takashi Oshima, Masahiro Okada, Takamichi Murakami, Shigeo Takebayashi, Shin Maeda, Yoshiaki Inayama, Masayuki Nakano, Katsuaki Tanaka. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver diseaseAbdominal Imaging 2015; 40(7): 2372 doi: 10.1007/s00261-015-0489-6
2
Ahmet Burak Toros, Serkan Gokcay, Guven Cetin, Muhlis Cem Ar, Yesim Karagoz, Besir Kesici. Portal Hypertension and Myeloproliferative Neoplasms: A Relationship RevealedISRN Hematology 2013; 2013: 1 doi: 10.1155/2013/673781
3
Kazuya Sugimori, Kazushi Numata, Masahiro Okada, Hiromi Nihonmatsu, Shigeo Takebayashi, Shin Maeda, Masayuki Nakano, Katsuaki Tanaka. Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced USJournal of Medical Ultrasonics 2017; 44(1): 89 doi: 10.1007/s10396-016-0750-9
4
Kazuto Kozaka, Satoshi Kobayashi, Norihide Yoneda, Azusa Kitao, Kotaro Yoshida, Dai Inoue, Takahiro Ogi, Wataru Koda, Yasunori Sato, Toshifumi Gabata, Osamu Matsui. Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological featuresEuropean Radiology 2019; 29(12): 6489 doi: 10.1007/s00330-019-06329-y
5
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_118-1
6
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 2091 doi: 10.1007/978-3-319-26956-6_118
7
Parit Mekaroonkamol, Robert Cohen, Saurabh Chawla. Portal hypertensive enteropathyWorld Journal of Hepatology 2015; 7(2): 127-138 doi: 10.4254/wjh.v7.i2.127
8
Vatsala Misra, Ranjan Agrawal, SriPraksh Misra. Portal hypertensive vasculopathy – An entity worth remembering with non-neoplastic gastrointestinal lesionsIndian Journal of Pathology and Microbiology 2021; 64(5): 32 doi: 10.4103/ijpm.ijpm_201_21
9
Christopher R. Reilly, Daria V. Babushok, Karlyn Martin, Jerry L. Spivak, Michael Streiff, Ranjeeta Bahirwani, Jeffrey Mondschein, Brady Stein, Alison Moliterno, Elizabeth O. Hexner. Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN‐associated portal hypertensionAmerican Journal of Hematology 2017; 92(9): 909 doi: 10.1002/ajh.24798
10
Kazuya SUGIMORI, Kazushi NUMATA, Masahiro OKADA, Hiromi NIHONMATSU, Shigeo TAKEBAYASHI, Shin MAEDA, Masayuki NAKANO, Katsuaki TANAKA. Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced USChoonpa Igaku 2019; 46(3): 225 doi: 10.3179/jjmu.JJMU.K.17
11
Mili Shah, Razia Gill, Priya Hotwani, Hamsika Moparty, Naresh Kumar, Dhir Gala, Vikash Kumar. A Case of Non-cirrhotic Portal Hypertension With Antiphospholipid SyndromeCureus 2024;  doi: 10.7759/cureus.53843